VEGF signaling has distinct spatiotemporal roles during heart valve development.
Heart valve malformations are one of the most common types of birth defects, illustrating the complex nature of valve development. Vascular endothelial growth factor (VEGF) signaling is one pathway implicated in valve formation, however its specific spatial and temporal roles remain poorly defined. To decipher these contributions, we use two inducible dominant negative approaches in mice to disrupt VEGF signaling at different stages of embryogenesis. At an early step in valve development, VEGF signals are required for the full transformation of endocardial cells to mesenchymal cells (EMT) at the outflow tract (OFT) but not atrioventricular canal (AVC) endocardial cushions. This role likely involves signaling mediated by VEGF receptor 1 (VEGFR1), which is highly expressed in early cushion endocardium before becoming downregulated after EMT. In contrast, VEGFR2 does not exhibit robust cushion endocardium expression until after EMT is complete. At this point, VEGF signaling acts through VEGFR2 to direct the morphogenesis of the AVC cushions into mature, elongated valve leaflets. This latter role of VEGF requires the VEGF-modulating microRNA, miR-126. Thus, VEGF roles in the developing valves are dynamic, transitioning from a differentiation role directed by VEGFR1 in the OFT to a morphogenetic role through VEGFR2 primarily in the AVC-derived valves.
Stankunas
Kryn
K
Division of Cardiovascular Medicine, Department of Medicine, Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
Ma
Gene K
GK
Kuhnert
Frank J
FJ
Kuo
Calvin J
CJ
Chang
Ching-Pin
CP
D000818:Animals; D019521:Body Patterning / Q000235:genetics / Q000502:physiology; D004699:Endocardium / Q000196:embryology; D005260:Female; D018507:Gene Expression Regulation, Developmental; D006351:Heart Valves / Q000196:embryology*; D008648:Mesoderm / Q000196:embryology; D051379:Mice; D008822:Mice, Transgenic; D035683:MicroRNAs / Q000235:genetics; D008955:Models, Cardiovascular; D011247:Pregnancy; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics / Q000502:physiology*; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000235:genetics / Q000502:physiology; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000235:genetics / Q000502:physiology
C545201:MIRN126 microRNA, mouse; D035683:MicroRNAs; D042461:Vascular Endothelial Growth Factor A; C467480:vascular endothelial growth factor A, mouse; D040281:Vascular Endothelial Growth Factor Receptor-1; D040301:Vascular Endothelial Growth Factor Receptor-2
Dev Biol. 1973 Dec;35(2):332-48
4274694
Genesis. 2003 May;36(1):7-11
12748962
Cell. 2008 Mar 7;132(5):875-86
18329372
Dev Biol. 2005 Oct 1;286(1):299-310
16140292
Biochim Biophys Acta. 1998 Jun 16;1398(2):157-63
9689915
Circulation. 2004 Oct 19;110(16):2424-9
15477417
Anat Rec A Discov Mol Cell Evol Biol. 2003 Mar;271(1):202-8
12552636
Development. 2005 Jul;132(14):3293-303
15944181
Mech Dev. 2002 Oct;118(1-2):199-202
12351187
Development. 2005 Dec;132(24):5601-11
16314491
Nature. 2008 Sep 4;455(7209):44-5
18769430
Circulation. 2007 Jun 12;115(23):3015-38
17519398
J Biol Chem. 2003 Jan 17;278(3):1686-92
12427739
J Cell Biol. 2004 Aug 2;166(3):359-67
15289495
Mol Cell Biol. 2005 Mar;25(6):2441-9
15743836
Dev Dyn. 1997 Jul;209(3):296-309
9215644
Cell. 2007 Apr 20;129(2):303-17
17397913
Am J Anat. 1977 Jan;148(1):85-119
842477
Philos Trans R Soc Lond B Biol Sci. 2007 Aug 29;362(1484):1489-503
17569640
Development. 2000 Sep;127(18):3941-6
10952892
Dev Biol. 1985 Dec;112(2):414-26
3935503
Circ Res. 2000 Feb 4;86(2):E29-35
10666423
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9349-54
9689083
Nature. 2003 Jan 9;421(6919):172-7
12520305
Genes Dev. 2004 Jan 1;18(1):99-115
14701881
Nature. 1998 Mar 12;392(6672):182-6
9515963
J Biol Chem. 1994 Oct 14;269(41):25646-54
7929268
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6502-7
15096597
Dev Biol. 1999 Aug 15;212(2):307-22
10433823
Anat Sci Int. 2009 Sep;84(3):77-87
19288174
Cell. 2002 Apr;109 Suppl:S67-79
11983154
Mol Cell Biol. 2007 Nov;27(21):7683-92
17724086
Nature. 1996 Apr 4;380(6573):439-42
8602242
Circ Res. 2009 Sep 11;105(6):565-74
19661463
J Exp Med. 2001 Mar 5;193(5):607-20
11238591
Development. 2000 Apr;127(7):1445-53
10704390
Development. 2003 Jan;130(1):209-20
12441304
Dev Biol. 2007 Jan 1;301(1):276-86
16959237
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4605-10
11274374
Histochem Cell Biol. 2003 Aug;120(2):103-10
12883905
Lung Cancer. 2009 Nov;66(2):169-75
19223090
Dev Cell. 2008 Aug;15(2):261-71
18694565
Circ Res. 2004 Sep 3;95(5):459-70
15345668
Dev Biol. 1983 Jan;95(1):108-14
6825921
J Biol Chem. 2007 Oct 19;282(42):30673-9
17693409
Development. 2008 Nov;135(21):3577-86
18849531
Nat Med. 2003 Feb;9(2):173-82
12539040
Dev Cell. 2008 Feb;14(2):298-311
18267097
Development. 2004 Sep;131(18):4477-87
15342473
N Engl J Med. 2000 Jan 27;342(4):256-63
10648769
Nature. 1996 Apr 4;380(6573):435-9
8602241
Nature. 2005 Aug 18;436(7053):1048-52
16107853
Development. 2008 Dec;135(24):3989-93
18987025
Nat Med. 2003 Jun;9(6):669-76
12778165
Nat Immunol. 2004 Jan;5(1):74-80
14634646
Nature. 1995 Jul 6;376(6535):62-6
7596435
Dev Cell. 2008 Aug;15(2):272-84
18694566
Proc Natl Acad Sci U S A. 2001 May 8;98(10):5780-5
11331753
Mol Cell. 2003 Dec;12(6):1615-24
14690613
Mol Cell Biol. 2008 Aug;28(15):4843-50
18519586
Development. 2001 May;128(9):1531-8
11290292
Dev Biol. 1999 Apr 15;208(2):530-45
10191064
Nature. 1998 Mar 12;392(6672):186-90
9515964
Mol Cell Biol. 1999 Mar;19(3):2032-43
10022890
Nat Genet. 2003 Nov;35(3):215-7
14528307
Circ Res. 2008 Sep 26;103(7):702-9
18723445
Nat Med. 2001 May;7(5):575-83
11329059
Nature. 1995 Jul 6;376(6535):66-70
7596436
Genes Dev. 2005 Feb 15;19(4):489-501
15713842
Cell. 1998 Mar 20;92(6):735-45
9529250
Genes Dev. 2006 Jun 15;20(12):1651-66
16778080
Cell. 2004 Sep 3;118(5):649-63
15339668